Showing 2371-2380 of 19322 results for "".
The Renewed Relevance of Evidence-Based Guidelines for Patient-Centered Infertility Care
https://reachmd.com/programs/global-womens-health-academy/renewed-relevance-evidence-based-guidelines-patient-centered-infertility-care/9452/The current clinical approach to investigating and managing infertility is supported by the evidence-based guidelines issued by the Royal College of Obstetricians and Gynaecologists (RCOG), the American Society of Reproductive Medicine (ASRM) and the European Society of Human Reproduction and EmbryoSpecial Diagnostic Considerations for Inflammatory Bowel Disease
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/special-diagnostic-considerations-inflammatory-bowel-disease/8563/Laura Wingate and Dr. David Binion discuss newer diagnostic modalities and ways to incorporate them into both classic and uncommon presentations.Anemia Care for IBD Patients
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/anemia-care-ibd-patients/8565/Dr. Jason Hou explores iron deficiency and chronic blood loss as common causes of anemia in patients with Crohn’s disease and ulcerative colitis.DocBookMD: A Physician's Journey Toward Improving Patient Care
https://reachmd.com/programs/voices-from-american-medicine/docbookmd-physicians-journey-toward-improving-patient-care/7544/Host Frank Russomano welcomes Dr. Tracey Haas, Chief Medical Officer of DocbookMD, an innovative communication platform for health care providers. Dr. Haas shares her story of how she and her husband, Dr. Tim Gueramy, discovered DocBookMD, the challenges of being a physician entreprenuer, and how shHow to Manage Insect Allergy: From Military to First Responders
https://reachmd.com/programs/hot-topics-in-allergy/how-to-manage-insect-allergy-from-military-to-first-responders/4026/How do insect allergies present challenges in emergency situations to first responders? What are the best ways to diagnose and treat anaphylaxis in patients away from a clinical setting? Host Dr. Ketan Sheth talks with Dr. Renata Engler, associate professor in the department of medicine at the UnifoUniversal Implications of DES
https://reachmd.com/programs/clinicians-roundtable/universal-implications-of-des/686/In long term data presented from the RAVEL trial, the original trial reporting a remarkable decrease in the rate of restenosis with DES, the long-term incidence of death or heart attack was not significantly different between DES and bare metal stents.ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
https://reachmd.com/programs/project-oncology/ctdna-immunotherapy-survival-mibc-imvigor011/36307/Presented at the 2025 ESMO Congress, the IMvigor011 phase 3 trial evaluated a ctDNA-guided strategy for administering adjuvant atezolizumab in patients with muscle-invasive bladder cancer (MIBC) following radical cystectomy. Patients with high-risk pathological features were monitored using a personRethinking PBC Care: Inside the RESPONSE Trial
https://reachmd.com/programs/gi-insights/primary-biliary-cholangitis-care-response-trial/49147/The phase 3 RESPONSE trial evaluated the efficacy and safety of seladelpar, a selective PPAR delta agonist, in patients with primary biliary cholangitis (PBC) who had an inadequate response to ursodeoxycholic acid. Tune in to hear Dr. Gideon Hirschfield and Dr. Brian McDonough discuss the design andAnalyzing IL-31 and the Benefits of Blocking It
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/analyzing-il-31-and-the-benefits-of-blocking-it/48777/James Q. Del Rosso, DO, FAOCD, discusses IL-31 and its involvement with itch, impairment of skin barrier function, and increased fibrosis of the skin.Individualizing gMG Treatment: Defining Success With Each Patient
https://reachmd.com/programs/neurofrontiers/individualizing-gmg-treatment-defining-success-with-each-patient/32862/As treatment options for generalized myasthenia gravis (gMG) expand, defining success means more than just controlling symptoms—it means aligning care with each patient’s goals and lifestyle. Hear Dr. Omar Sinno, who spoke with ReachMD at the AANEM 2025 Annual Meeting in San Francisco, share insight